Olav Hellebø
Cytovation appoints Olav Hellebø to board of directors
July 5, 2023Business Services Cytovation, Olav Hellebø, Oncology, appointment, board of directors
Cytovation ASA, a clinical stage immune-oncology company with a focus on targeted tumour membrane immunotherapies, has announced that it has …
New chief executive for ReNeuron
September 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Olav Hellebø, ReNeuron, clavis
UK-based stem cell therapy firm ReNeuron has appointed Olav Hellebø to be its new chief executive. Since starting his pharma …
Pharmalink elects three to board
July 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ann-Tove Kongsnes, Hilde Furberg, Olav Hellebø, Pharmalink, ab
Swedish speciality pharma firm Pharmalink AB has appointed Ann-Tove Kongsnes, Hilde Furberg and Olav Hellebø to its board of directors. …
Latest content
Report highlights scope to expand day surgery
September 23, 2026
Sygnature formalises drug discovery collaboration with X-Chem
September 22, 2026
Codis appoints Steven Facer as chief commercial officer
September 21, 2026
Danish medical cannabis use rises as regulator reports no new safety signals
September 21, 2026
